ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease

Vascular Medicine

Volumn 15, Issue 6, 2010, Pages 481-512

  Olin, Jeffrey W ^c   Allie, David E ^a   Belkin, Michael ^b   Bonow, Robert O ^c   Casey Jr , Donald E ^d   Creager, Mark A ^c   Gerber, Thomas C ^e   Hirsch, Alan T ^c   Jaff, Michael R ^f   Kaufman, John A ^c   Lewis, Curtis A ^g   Martin, Edward T ^h   Martin, Louis G ⁱ   Sheehan, Peter ^j   Stewart, Kerry J ^k   Treat Jacobson, Diane ^l   White, Christopher J ^m   Zheng, Zhi Jie ⁿ  

^a Society of Cardiovascular Computed Tomography Representative   (United States)

^b Society for Vascular Surgery Representative   (United States)

^c ACCF/AHA Task Force on Performance Measures Liaison ^*

^d AMERICAN COLLEGE OF PHYSICIANS   (United States)

^e Society for Atherosclerosis Imaging and Prevention Representative   (United States)

^f Society for Vascular Medicine Representative   (United States)

^g American College of Radiology Representative   (United States)

^h Society for Cardiovascular Magnetic Resonance Representative   (United States)

ⁱ Society for Interventional Radiology Representative   (United States)

^j AMERICAN DIABETES ASSOCIATION   (United States)

^k American Association of Cardiovascular and Pulmonary Rehabilitation Representative   (United States)

^l Society for Vascular Nursing Representative   (United States)

^m Society for Cardiac Angiography and Interventions Representative   (United States)

ⁿ NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ABDOMINAL AORTA ANEURYSM; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; BYPASS SURGERY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIABETES MELLITUS; EXERCISE; HUMAN; HYPERTENSION; LEG ISCHEMIA; LIMB ISCHEMIA; MAGNETIC RESONANCE ANGIOGRAPHY; MESENTERIC ARTERY; OUTCOME ASSESSMENT; PATIENT CARE; PERFORMANCE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; RENAL ARTERY; REVASCULARIZATION; SCREENING TEST; SMOKING CESSATION; TREADMILL EXERCISE;

ADULT; ADVISORY COMMITTEES; AMERICAN HEART ASSOCIATION; BENCHMARKING; DIAGNOSTIC IMAGING; EVIDENCE-BASED MEDICINE; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PERIPHERAL ARTERIAL DISEASE; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; QUALITY INDICATORS, HEALTH CARE; RISK ASSESSMENT; RISK FACTORS; SOCIETIES, MEDICAL; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 78650680607     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358863X10390838     Document Type: Article

References (73)

1. Institute of Medicine. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academy Press, 2001.
2. Bonow RO, Bennett S., Casey DE Jr, et al. ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures). J Am Coll Cardiol 2005 ; 46: 1144-1178.
3. American Medical Association Physician Consortium for Performance Improvement. Clinical performance measures: chronic stable coronary artery disease, http://www.ama-assn.org/ama1/pub/upload/mm/370/cadminisetjune06.pdf (accessed January 5, 2010 ).
4. American Medical Association Physician Consortium for Performance Improvement. Clinical performance measures: hypertension, http://www.ama-assn. org/ama1/pub/upload/mm/370/hypertension-8-05.pdf (accessed January 5, 2010 ).
5. Krumholz HM, Anderson JL, Brooks NH, et al. ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction). J Am Coll Cardiol 2006 ; 47: 236-265.
6. Krumholz HM, Anderson JL, Bachelder BL, et al. ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for ST-Elevation and Non-ST-Elevation Myocardial Infarction). J Am Coll Cardiol 2008 ; 52: 2046-2099.
7. Thomas RJ, King M., Lui K., et al. AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services. J Am Coll Cardiol 2007 ; 50: 1400-1433.
8. Thomas RJ, King M., Lui K., et al. AACVPR/ACCF/AHA 2010 update: performance measures on cardiac rehabilitation for referral to cardiac rehabilitation/secondary prevention services. J Am Coll Cardiol 2010 ; 56: 1159-1167.
9. Estes NA III, Halperin JL, Calkins H., et al. ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with non-valvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation). J Am Coll Cardiol 2008 ; 51: 865-884.
10. Redberg RF, Benjamin EJ, Bittner V., et al. ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease). J Am Coll Cardiol 2009 ; 54: 1364-1405.
11. Spertus JA, Eagle KA, Krumholz HM, et al. American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care. J Am Coll Cardiol 2005 ; 45: 1147-1156.
12. Krumholz HM, Brindis RG, Brush JE, et al. Standards for statistical models used for public reporting of health outcomes: an American Heart Association scientific statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group: cosponsored by the Council on Epidemiology and Prevention and the Stroke Council. Circulation 2006 ; 113: 456-462.
13. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). J Am Coll Cardiol 2006 ; 47: e1-192.
14. Creager MA, White CJ, Hiatt WR, et al. Atherosclerotic Peripheral Vascular Disease Symposium II: executive summary. Circulation 2008 ; 118: 2811-2825.
15. Hiatt WR, Goldstone J., Smith SC Jr, et al. Atherosclerotic Peripheral Vascular Disease Symposium II: nomenclature for vascular diseases. Circulation 2008 ; 118: 2826-2829.
16. Rosamond W., Flegal K., Furie K., et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008 ; 117: e25-146.
17. Criqui MH, Fronek A., Barrett-Connor E., et al. The prevalence of peripheral arterial disease in a defined population. Circulation 1985 ; 71: 510-515.
18. Kannel WB, McGee DL Update on some epidemiologic features of intermittent claudiation: the Framingham Study. J Am Geriatr Soc 1985 ; 33: 13-18.
19. Regensteiner JG, Hiatt WR Current medical therapies for patients with peripheral arterial disease: a critical review. Am J Med 2002 ; 112: 49-57.
20. Hirsch AT, Criqui MH, Treat-Jacobson D., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001 ; 286: 1317-1324.
21. McDermott MM, Greenland P., Liu K., et al. The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med 2002 ; 136: 873-883.
22. Barletta G., Perna S., Sabba C., et al. Quality of life in patients with intermittent claudication: relationship with laboratory exercise performance. Vasc Med 1996 ; 1: 3-7.
23. Khaira HS, Hanger R., Shearman CP Quality of life in patients with intermittent claudication. Eur J Vasc Endovasc Surg 1996 ; 11: 65-69.
24. Pell JP Impact of intermittent claudication on quality of life. The Scottish Vascular Audit Group. Eur J Vasc Endovasc Surg 1995 ; 9: 469-472.
25. Ponte E., Cattinelli S. Quality of life in a group of patients with intermittent claudication. Angiology 1996 ; 47: 247-251.
26. Treat-Jacobson D., Halverson S., Ratchford A., et al. A patient-derived perspective of health-related quality-of-life in peripheral arterial disease. J Nurs Scholarsh 2002 ; 34: 55-60.
27. Smolderen KG, Aquarius AE, de Vries J., et al. Depressive symptoms in peripheral arterial disease: a follow-up study on prevalence, stability, and risk factors. J Affect Disord 2008 ; 110: 27-35.
28. Vogt MT, Cauley JA, Newman AB, et al. Decreased ankle/arm blood pressure index and mortality in elderly women. JAMA 1993 ; 270: 465-469.
29. McKenna M., Wolfson S., Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 1991 ; 87: 119-128.
30. Newman AB, Shemanski L., Manolio TA, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999 ; 19: 538-545.
31. Criqui MH, Coughlin SS, Fronek A. Noninvasively diagnosed peripheral arterial disease as a predictor of mortality: results from a prospective study. Circulation 1985 ; 72: 768-773.
32. Newman AB, Tyrrell KS, Kuller LH Mortality over four years in SHEP participants with a low ankle-arm index. J Am Geriatr Soc 1997 ; 45: 1472-1478.
33. Resnick HE, Lindsay RS, McDermott MM, et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 2004 ; 109: 733-739.
34. Criqui MH, Langer RD, Fronek A., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992 ; 326: 381-386.
35. Leng GC, Lee AJ, Fowkes FG, et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 1996 ; 25: 1172-1181.
36. Criqui MH, Denenberg JO, Langer RD, et al. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med 1997 ; 2: 221-226.
37. Ness J., Aronow WS Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice. J Am Geriatr Soc 1999 ; 47: 1255-1256.
38. Zheng ZJ, Sharrett AR, Chambless LE, et al. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 1997 ; 131: 115-125.
39. Burek KA, Sutton-Tyrrell K., Brooks MM, et al. Prognostic importance of lower extremity arterial disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol 1999 ; 34: 716-721.
40. Saw J., Bhatt DL, Moliterno DJ, et al. The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials. J Am Coll Cardiol 2006 ; 48: 1567-1572.
41. Norgren L., Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007 ; 33 Suppl 1: 1-75.
42. Normand SL, McNeil BJ, Peterson LE, et al. Eliciting expert opinion using the Delphi technique: identifying performance indicators for cardiovascular disease. Int J Qual Health Care 1998 ; 10: 247-260.
43. Steg PG, Bhatt DL, Wilson PW, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007 ; 297: 1197-1206.
44. Diehm C., Lange S., Darius H., et al. Association of low ankle brachial index with high mortality in primary care. Eur Heart J 2006 ; 27: 1743-1749.
45. Selvin E., Hirsch AT Contemporary risk factor control and walking dysfunction in individuals with peripheral arterial disease: NHANES 1999-2004. Atherosclerosis 2008 ; 201: 425-433.
46. Feringa HH, van Waning VH, Bax JJ, et al. Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease. J Am Coll Cardiol 2006 ; 47: 1182-1187.
47. McDermott MM, Hahn EA, Greenland P., et al. Atherosclerotic risk factor reduction in peripheral arterial diseasea: results of a national physician survey. J Gen Intern Med 2002 ; 17: 895-904.
48. McDermott MM, Mandapat AL, Moates A., et al. Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral arterial disease. Arch Intern Med 2003 ; 163: 2157-2162.
49. Perlstein TS, Creager MA The ankle-brachial index as a biomarker of cardiovascular risk: it's not just about the legs. Circulation 2009 ; 120: 2033-2035.
50. Fowkes FG, Murray GD, Butcher I., et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008 ; 300: 197-208.
51. Berger JS, Krantz MJ, Kittelson JM, et al. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials. JAMA 2009 ; 301: 1909-1919.
52. Fowkes FG, Price JF, Stewart MC, et al. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. JAMA 2010 ; 303: 841-848.
53. Hiatt WR Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001 ; 344: 1608-1621.
54. Stewart KJ, Hiatt WR, Regensteiner JG, et al. Exercise training for claudication. N Engl J Med 2002 ; 347: 1941-1951.
55. Bandyk DF, Schmitt DD, Seabrook GR, et al. Monitoring functional patency of in situ saphenous vein bypasses: the impact of a surveillance protocol and elective revision. J Vasc Surg 1989 ; 9: 286-296.
56. Lundell A., Lindblad B., Bergqvist D., et al. Femoropopliteal-crural graft patency is improved by an intensive surveillance program: a prospective randomized study. J Vasc Surg 1995 ; 21: 26-33.
57. Davies AH, Hawdon AJ, Sydes MR, et al. Is Duplex surveillance of value after leg vein bypass grafting? Principal results of the Vein Graft Surveillance Randomised Trial (VGST). Circulation 2005 ; 112: 1985-1991.
58. Cooper CJ, Murphy TP, Matsumoto A., et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J 2006 ; 152: 59-66.
59. National Diabetes Quality Improvement Alliance. Performance measurement set for adult diabetes, http://www.-nehc.med.navy.mil/bumed/diabetes/ document%20folders/diabetes/cpg/dqia.msrs.pdf (accessed January 5, 2010 ).
60. National Quality Forum. National voluntary consensus standards for ambulatory care: diabetes care measures, http://www.qualityforum.org/ Publications/2008/03/National-Voluntary-Consensus-Standards-for-Ambulatory- Care%E2%80%93Part-2.aspx (accessed December 24, 2009 ).
61. Fleming C., Whitlock EP, Beil TL, et al. Screening for abdominal aortic aneurysm: a best-evidence systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2005 ; 142: 203-211 ).
62. Kent KC, Zwolak RM, Jaff MR, et al. Screening for abdominal aortic aneurysm: a consensus statement. J Vasc Surg 2004 ; 39: 267-269.
63. Screening for abdominal aortic aneurysm recommendation statement. Ann Intern Med 2005 ; 142: 198-202.
64. Ashton HA, Gao L., Kim LG, et al. Fifteen-year follow-up of a randomized clinical trial of ultrasonographic screening for abdominal aortic aneurysms. Br J Surg 2007 ; 94: 696-701.
65. Cosford PA, Leng GC Screening for abdominal aortic aneurysm. CD002945 Cochrane Database Syst Rev 2007 ; CD002945.
66. Lindholt JS, Norman P. Screening for abdominal aortic aneurysm reduces overall mortality in men. A meta-analysis of the mid- and long-term effects of screening for abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2008 ; 36: 167-171.
67. Kim LG, Scott Rap, Ashton HA, et al. A sustained mortality benefit from screening for abdominal aortic aneurysm. Ann Intern Med 2007 ; 146: 699-706.
68. Olin JW Long-term outcomes and cost-effectiveness of screening for abdominal aortic aneurysm. Nat Clin Pract Cardiovasc Med 2007 ; 4: 650-651.
69. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals a randomised placebo-controlled trial. Lancet 2002 ; 360: 7-22.
70. Smith SC Jr, Allen J., Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. J Am Coll Cardiol 2006 ; 47: 2130-2139.
71. The Vascular Disease Foundation (VDF) and the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR). P.A.D. exercise training toolkit: a guide for health care professionals, http://www.vdf.org/ professionals/exercisetoolkit.php (accessed May 25, 2010 ).
72. American College of Sports Medicine. ACSM's guidelines for exercise testing and prescription, 7 th edition. Baltimore, MD: Lippincott Williams & Wilkins, 2006.
73. Penchansky R., Thomas JW The concept of access: definition and relationship to consumer satisfaction. Med Care 1981 ; 19: 127-140.